register free | resend password

EnWave Signs Non-Exclusive License with Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer

ID: 1327423
recent pressrelease next pressrelease

(businesspress24) - EnWave Signs Non-Exclusive License with Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer
Vancouver, B.C., December 29, 2014
EnWave Corporation (TSX-V:ENW | FSE:E4U) (EnWave, or the "Company" today announced that it has signed a non-exclusive Research and Development License Agreement (the Agreement) with Merck (Merck), known as MSD outside the United States and Canada, through a subsidiary to enable testing and advancement of the Companys Radiant Energy Vacuum (REV) dehydration technology in the pharmaceutical industry.

This latest license builds upon a prior agreement signed in 2012 with Merck that provided for activities on an exclusive basis. With this new arrangement, EnWave can now actively pursue additional research partners in the pharmaceutical industry in an effort to promote eventual widespread adoption of REV technology as a replacement for lyophilization.

Under the terms of the 10 year Agreement, both parties have established a work plan for the production of a specifically designed non-GMP REV dryer. EnWave will be eligible for undisclosed milestone payments associated with the progress of the project. Further terms of the Agreement were not disclosed. Merck will retain an option to exclusively license REV for the drying of several specific vaccines.

About EnWave
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. EnWave aims to sign royalty-bearing commercial licenses with leading food and pharmaceutical companies for the use of its revolutionary technology. Thus far the Company has signed twelve royalty-bearing licenses, opening up eight distinct market sectors for commercialization with companies that include Bonduelle, a global leader in the production of vegetables; Hormel Foods Corporation, a major processed meat manufacturer in the United States of America; and Sutro Biopharma, a company developing a protein synthesis process for the pharmaceutical industry. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand. The Company has also signed a license and manufacturing agreement with NutraDried Creations to market the dried cheese and other REV snack products through private label distribution channels in the United States and Latin America.

EnWave has signed a wide range of research agreements with an expanding list of companies that include Nestlé, Kelloggs, Ocean Spray Cranberries, Sun-Maid Growers, R.J. Reynolds and Merck among others. EnWave is introducing REV as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has five REV platforms: commercial-scale nutraREV® is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company has also commercialized powderREV® for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point and quantaREV for continuous, high-volume low-temperature drying. Both bioREV and freezeREV are being developed as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at

EnWave Corporation
Dr. Tim Durance
President, CEO and Director

For further information:

Mr. John Budreski, Executive Chairman, EnWave Corporation at +1 (416) 930-0914E-mail: jbudreski(at)

Mr. Brent Charleton, Vice President, Corporate Affairs at +1 (778) 378-9616E-mail: bcharleton(at)
EnWave Corporation
Suite 2000 - 1066 West Hastings St.,
Vancouver, B.C.,
Tel (604) 806-6110 Fax (604) 806-6112
TSX Venture Exchange trading symbol: ENW

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management''s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company''s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Keywords (optional):

Company information / Profile:

PressRelease by


EnWave Corporation ist ein in Vancouver ansässiges Technologieunternehmen das kommerzielle Applikationen für ihre geschützte Radiant Energy Vacuum (REV™) Trocknungstechnologie anbietet.

PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 12/29/2014 - 15:19
Language: English
News-ID 1327423
Character count: 0
Firma: EnWave Corporation
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 383


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 58

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.